Simulation-Based Sample Size Estimation in Clinical Trials in Nephrology.
作者信息
Zelnick Leila R
机构信息
Division of Nephrology, Kidney Research Institute, University of Washington, Seattle, Washington.
出版信息
J Am Soc Nephrol. 2025 Mar 1;36(3):522-524. doi: 10.1681/ASN.0000000560. Epub 2024 Oct 24.
Abstract
摘要
相似文献
1
Simulation-Based Sample Size Estimation in Clinical Trials in Nephrology.肾脏病临床试验中基于模拟的样本量估计
J Am Soc Nephrol. 2025 Mar 1;36(3):522-524. doi: 10.1681/ASN.0000000560. Epub 2024 Oct 24.
2
Sex and gender considerations in randomized controlled trials in critical care nephrology: a meta-epidemiologic study.危重症肾脏病学随机对照试验中的性别与性别的考量：一项元流行病学研究
BMC Med. 2025 Jul 1;23(1):386. doi: 10.1186/s12916-025-04202-y.
3
A Systematic Bibliometric Analysis of High-Impact Articles in Critical Care Nephrology.重症肾脏病学高影响力文章的系统文献计量学分析。
Blood Purif. 2024;53(4):243-267. doi: 10.1159/000535558. Epub 2023 Dec 5.
4
The prognostic reasoning system for chronic kidney disease progression (PROGRES-CKD) may help improve waiting list management for outpatient nephrology services in a second-level public hospital in Italy.慢性肾脏病进展预后推理系统（PROGRES-CKD）可能有助于改善意大利一家二级公立医院门诊肾病服务的等候名单管理。
J Nephrol. 2025 Feb 27. doi: 10.1007/s40620-025-02222-8.
5
Pediatric Nephrology Practice in the United States: Survey of Pediatric Nephrology Division Directors.美国儿科肾脏病学实践：儿科肾脏病学部门主任调查
Am J Kidney Dis. 2025 Jul;86(1):74-83. doi: 10.1053/j.ajkd.2025.01.025. Epub 2025 Apr 4.
6
Evaluation and optimization of sample size of neonates and infants for pediatric clinical studies on cefiderocol using a model-based approach.基于模型的方法评估和优化头孢地尔在儿科临床研究中新生儿和婴儿的样本量。
Pharmacol Res Perspect. 2024 Oct;12(5):e70001. doi: 10.1002/prp2.70001.
7
Blinded sample size re-estimation in three-arm trials with 'gold standard' design.采用“金标准”设计的三臂试验中的盲法样本量重新估计。
Stat Med. 2017 Oct 15;36(23):3636-3653. doi: 10.1002/sim.7356. Epub 2017 Jun 12.
8
Innovations in randomized clinical trials in Nephrology: from study design to patient's activism.肾脏病学随机临床试验的创新：从研究设计到患者行动主义。
G Ital Nefrol. 2025 Jun 30;42(3):2025-vol3. doi: 10.69097/42-03-2025-02.
9
Artificial intelligence in nephrology education: a multicenter survey of fellowship trainees at Mayo Clinic.肾脏病学教育中的人工智能：梅奥诊所住院医师培训学员的多中心调查
Front Nephrol. 2025 Jun 18;5:1607017. doi: 10.3389/fneph.2025.1607017. eCollection 2025.
10
Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review.慢性肾脏病中早期与晚期肾脏病专科转诊的结局：系统评价。
Am J Med. 2011 Nov;124(11):1073-80.e2. doi: 10.1016/j.amjmed.2011.04.026.
本文引用的文献
1
Simplification or simulation: Power calculation in clinical trials.简化或模拟：临床试验中的功效计算
Contemp Clin Trials. 2022 Feb;113:106663. doi: 10.1016/j.cct.2021.106663. Epub 2021 Dec 24.
2
Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis.HiLo 研究的设计与原理：维持性血液透析患者磷管理的实用随机临床试验。
Am J Kidney Dis. 2021 Jun;77(6):920-930.e1. doi: 10.1053/j.ajkd.2020.10.008. Epub 2020 Dec 3.
3
The quality of the reported sample size calculations in randomized controlled trials indexed in PubMed.在PubMed上索引的随机对照试验中报告的样本量计算质量。
Eur J Intern Med. 2017 May;40:16-21. doi: 10.1016/j.ejim.2016.10.008. Epub 2016 Oct 18.
4
Simulation methods to estimate design power: an overview for applied research.模拟方法估计设计功率：应用研究概述。
BMC Med Res Methodol. 2011 Jun 20;11:94. doi: 10.1186/1471-2288-11-94.
5
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.CONSORT 2010 声明：平行组随机试验报告的更新指南。
BMJ. 2010 Mar 23;340:c332. doi: 10.1136/bmj.c332.
6
Sample size calculations: basic principles and common pitfalls.样本量计算：基本原理和常见陷阱。
Nephrol Dial Transplant. 2010 May;25(5):1388-93. doi: 10.1093/ndt/gfp732. Epub 2010 Jan 12.
Zotero 插件